Article
Drug efflux and parC mutations are involved in fluoroquinolone resistance in viridans group streptococci.
Antimicrobial agents and chemotherapy - 1 Oct 1999
Ferrándiz M J, Oteo J, Aracil B, Gómez-Garcés J L, De La Campa A G
Abstract excerpt
Nine ciprofloxacin-resistant viridans group streptococci isolated from asymptomatic carriers were analyzed. Identification to the species level by using three different commercial systems and a PCR-based approach was inconsistent. The nucleotide sequences of fragments of the parC, parE, gyrA, and gyrB genes showed considerable intra- and interspecies variations, and these variations mainly involved silent...
Topics
- Anti-Infective Agents
- Bacterial Proteins
- Biological Transport
- DNA Gyrase
- DNA Topoisomerase IV
- DNA Topoisomerases, Type II
- DNA-Binding Proteins
- Drug Resistance, Microbial
- Fluoroquinolones
- Humans
